Clinical Trials in Salt Lake City

Showing 15501-15520 of 16,694 trials

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

NCT01051921

The purpose of this study is to determine if the combination treatment of CTS-1027, pegylated interferon and ribavirin can improve the response rates in HCV patients who did not previously respond to pegylated interferon and ribavirin therapy.

Hepatitis C

Conatus Pharmaceuticals Inc.67 participantsStarted Jan 2010

La Jolla, California, United States • San Diego, California, United States • Denver, Colorado, United States +12 more locations

COMPLETEDPhase 1< 1 mile

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

NCT00626158

The purpose of this study is to find out what effects gemcitabine plus capecitabine has on patients with pancreatic or biliary cancer, and to determine the optimal dose that can be given safely of these two drugs together (called the maximum tolerated dose). Gemcitabine and capecitabine are two chemotherapy drugs used to treat pancreatic and biliary cancer. These two drugs used together are considered an acceptable standard of care for pancreatic and biliary cancers. However, in this study the dose and dosing schedule will be changed, in the hopes that the drugs will have more effect with fewer side effects than when given in the standard way.

Pancreatic CancerBiliary Cancer

University of California, San Francisco45 participantsStarted Feb 2008

San Francisco, California, United States • Salt Lake City, Utah, United States

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Find Trials by Condition in Salt Lake City

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)

CTS-1027 in Interferon-Naive Hepatitis C Patients

Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension

Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma

Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder

EPO906 Therapy in Patients With Advanced Kidney Cancer

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

AZD7268 Safety and Tolerability Study

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder

A Study in the Treatment of Osteoarthritis Knee Pain

A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis